Skip to main content

Trinity College Dublin, The University of Dublin

Menu Search


Trinity College Dublin By using this website you consent to the use of cookies in accordance with the Trinity cookie policy. For more information on cookies see our cookie policy.

      
Profile Photo

Dr. David Kevans

Clinical Associate Professor (Clinical Medicine)
ST JAMESS HOSPITAL


  INFLAMMATORY-BOWEL-DISEASE
Details Date
Secretary Investigator Network for Inflammatory Bowel Disease in Ireland (INITiative) 01-Oct-2018
Board Member, Irish Society for Clinical Nutrition and Metabolism 01-Jan-2018
Language Skill Reading Skill Writing Skill Speaking
English Fluent Fluent Fluent
Details Date From Date To
Membership of Royal College Of Physicians of Ireland 2003 To date
Membership European Crohn's and Colitis Organisation 2014 To date
Principle Investigator Investigator Network for Inflammatory Bowel disease therapy in Ireland (INITIative) 2014 to date
Irish Society of Gastroenterology 01-Jul-2005 To date
J O'Connell, P McDonagh, N Clarke, A Buckley, C Dunne, K Hartery, J Larkin, F MacCarthy, P McCormack, S McKiernan, B Mehigan, C Muldoon, C Ryan, J O'Sullivan, D Kevans, Association between tissue oncostatin M expression and infliximab response in corticosteroid refractory acute severe ulcerative colitis, Journal of Crohn's and Colitis, European Crohn's and Colitis Organisation Annual Congress, Copenhagen, 1/3/2019, 13, 2019, ppS134 - S134, Conference Paper, PUBLISHED
J O'Connell, MS Ismail, M McCormack, P McDonagh, R Argue, N Breslin, V Crowley, G Cullen, GA Doherty, C Dunne, K Hartery, F MacCarthy, S McKiernan, H Mulcahy, A O'Connor, C O'Morain, B Ryan, J Sheridan, M Healy, D McNamara, D Kevans, Association between induction vedolizumab drug levels and therapy outcome in inflammatory bowel disease, Journal of Crohn's and Colitis, Euopean Crohn's and Colitis Organisation Annual Congress, Copenhagen, 1/3/2019, 13, 2019, ppS308 - S309, Conference Paper, PUBLISHED
J O'Connell, P McDonagh, K Hazel, J Fiona, C Dunne, R Farrell, G Harewood, K Hartery, O Kelly, F MacCarthy, S McKiernan, F Murray, C O'Morain, O Aoibhlinn, D Kevans, Association between trough levels of vedolizumab and therapy outcome in a cohort of patients with inflammatory bowel disease, Journal of Crohn's and Colitis, European Crohn's and Colitis Organisation Annual Congress, Copenhagen, 1/3/2019, 13, 2019, ppS473 - S473, Conference Paper, PUBLISHED
Gibson, David J., Doherty, Jayne, McNally, Mairead, Keogh, Aine M., Keegan, Denise, Byrne, Kathryn, Kennedy, Una, Mulcahy, Hugh E., McKiernan, Susan, MacCarthy, Finbar, Egan, Laurence, Cullen, Garret, Sheridan, Juliette, Sengupta, Subhasish, Slattery, Eoin, Kevans, David, Doherty, Glen A., Medium to Long Term Outcomes in Patients Receiving Accelerated Dose Infliximab Induction for Acute Severe Ulcerative Colitis (ASUC) in a Mulit-Centre Cohort, 154, (6), 2018, ppS-832 , Conference Paper, PUBLISHED  DOI
C. Judge, N. McGettigan, T. Ryan, K. Hazel, P. Singh, V. Parihar, R. Stack, A. O'Connor, C. Dunne, G. Cullen, L. Egan, G. Harewood, F. MacCarthy, S. McKiernan, H. Mulcahy, F. Murray, S. Patchett, J. Sheridan, D. Trevian, N. Breslin, R. Farrell, J. Keohane, O. Kelly, D. McNamara, B. Ryan, C. Smyth, C. O'Morain, S. Sengupta, E. Slattery, G. Doherty, D. Kevans, A. O'Toole, Effectiveness and safety of vedolizumab therapy in an ulcerative colitis cohort with significant prior anti-TNF exposure, Journal of Crohn's and Colitis, Euopean Crohn's and Colitis Organisation Annual Congress, Vienna, February 2018, 12, 2018, Conference Paper, PUBLISHED
Kevans D, Murthy S, Mould DR, Silverberg MS, Accelerated Clearance of Infliximab is Associated With Treatment Failure in Patients With Corticosteroid-Refractory Acute Ulcerative Colitis., Journal of Crohn's & colitis, 2018, Journal Article, PUBLISHED
Bell, A. and Conway, N. and Courtney, J. and Kennedy, K. and Raubenheimer, Z. and Rice, N. and Kevans, D. and Donohoe, C.L. and Reynolds, J.V., Point prevalence of adult intestinal failure in Republic of Ireland, Irish Medical Journal, 111, (2), 2018, p688 , Notes: [cited By 0], Journal Article, PUBLISHED
Sheridan J, Coe CA, Doran P, Egan L, Cullen G, Kevans D, Leyden J, Galligan M, O'Toole A, McCarthy J, Doherty G, Protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis) led by the INITIAtive group (NCT 0268772)., BMJ open gastroenterology, 2018, Journal Article, PUBLISHED
O'Connell J, Rowan C, Stack R, Harkin G, Parihar V, Chan G, Breslin N, Cullen G, Dunne C, Egan L, Harewood G, Leyden J, MacCarthy F, MacMathuna P, Mahmud N, McKiernan S, McNamara D, Mulcahy H, Murray F, O'Connor A, O'Toole A, Patchett S, Ryan B, Sheridan J, Slattery E, Doherty G, Kevans D., Golimumab effectiveness and safety in clinical practice for moderately active ulcerative colitis., Eur J Gastroenterol Hepatol, (9), 2018, p1019 - 1026, Journal Article, PUBLISHED
J O'Connell, S Keohane, A McGreal-Bellone, S Naimimohasse, S McKiernan, F MacCarthy, D O'Toole, J Meaney, D Kevans, Characteristics and outcomes of acute colitis presenting via the emergency department in an Irish academic medical centre, Journal of Crohn's and Colitis, European Crohn's and Colitis Organisation Annual Congress, Barcelona, 26/1/2017, 11, 2017, ppS147 - S148, Conference Paper, PUBLISHED  DOI
  

Page 1 of 5

  

Award Date
Fellowship Award, Canadian Institutes of Health Research 2012